Cullinan Oncology Inc
NASDAQ:CGEM

Watchlist Manager
Cullinan Oncology Inc Logo
Cullinan Oncology Inc
NASDAQ:CGEM
Watchlist
Price: 15.87 USD -2.16% Market Closed
Market Cap: 920.1m USD
Have any thoughts about
Cullinan Oncology Inc?
Write Note

Cullinan Oncology Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cullinan Oncology Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Cullinan Oncology Inc
NASDAQ:CGEM
Total Equity
$453.7m
CAGR 3-Years
32%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.3B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5.9B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$14.8B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$28.2B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
28%

See Also

What is Cullinan Oncology Inc's Total Equity?
Total Equity
453.7m USD

Based on the financial report for Dec 31, 2023, Cullinan Oncology Inc's Total Equity amounts to 453.7m USD.

What is Cullinan Oncology Inc's Total Equity growth rate?
Total Equity CAGR 5Y
69%

Over the last year, the Total Equity growth was -15%. The average annual Total Equity growth rates for Cullinan Oncology Inc have been 32% over the past three years , 69% over the past five years .

Back to Top